SUBSTITUIERTE XANTHINDERIVATE

Patent europeic · EP3894410 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3894410
Numer da la dumonda
EP19820718
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
10-12-2019
Publitgà
20-10-2021
Concedì
11-10-2023
Stritgà
23-07-2026
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 473/06 (2006.01)
A61P 25/24 (2006.01)
A61P 25/16 (2006.01)
A61P 25/22 (2006.01)
A61P 25/28 (2006.01)
A61P 25/18 (2006.01)
Prioritad
EP 18212060 12.12.2018
Dumonda PCT
PCT/EP2019/084375 10.12.2019
Publicaziun PCT
WO2020/120450 18.06.2020
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-07-2026

    Stritgà, taxa betg pajada

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.07.2026
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.07.2026

  2. 01-01-2025

    Next annual fee due on

    Next annual fee due on
    31.12.2024 → 31.12.2025

    Published in Swissreg on 01.01.2025

  3. 21-08-2024

    Midada

    Published in Swissreg on 21.08.2024

  4. 01-01-2024

    Midada

    Published in Swissreg on 01.01.2024

  5. 11-10-2023

    Concedì

    Published in Swissreg on 11.10.2023

Partidas

Possessur

Hydra Biosciences, LLC

405 Concord Avenue P.O. Box 147, Belmont, MA 02478, US

Boehringer Ingelheim International GmbH

Binger Strasse 173, 55216 Ingelheim am Rhein, DE

Inventur

GERLACH, Kai

55216 Ingelheim am Rhein, DE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.